Feasibility of prevention of type 2 diabetes in low- and middle-income countries Andre P. KengneAmbady Ramachandran Review Open access 15 February 2024 Pages: 763 - 772
Keeping pace: the primary cilium as the conducting baton of the islet Olof Idevall-HagrenCeren Incedal NilssonGonzalo Sanchez Review Open access 14 February 2024 Pages: 773 - 782
Harnessing the power of proteomics in precision diabetes medicine Nigel KurganJeppe Kjærgaard LarsenAtul S. Deshmukh Review 12 February 2024 Pages: 783 - 797
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis Milena JancevTessa A. C. M. VissersThomas T. van Sloten Article Open access 16 February 2024 Pages: 798 - 810
Safety, tolerability and immunogenicity of PRV-101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double-blind randomised placebo-controlled Phase I trial Heikki HyötySusanna KääriäinenMiguel Sanjuan Article Open access 19 February 2024 Pages: 811 - 821
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Pedro CardosoKatie G. Youngon behalf of the MASTERMIND consortium Article Open access 22 February 2024 Pages: 822 - 836
Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank Qiao JinEric S. H. Lauon behalf of the Hong Kong Diabetes Biobank Study Group Article Open access 27 February 2024 Pages: 837 - 849
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment Mengqi SuYilin HouCong Chen Article Open access 27 February 2024 Pages: 850 - 863
Child-to-adult body size change and risk of type 2 diabetes and cardiovascular disease Germán D. CarrasquillaLars ÄngquistRuth J. F. Loos Article Open access 12 December 2023 Pages: 864 - 873
Low birthweight and overweight during childhood and young adulthood and the risk of type 2 diabetes in men: a population-based cohort study Jimmy CélindMaria BygdellJenny M. Kindblom Article Open access 22 February 2024 Pages: 874 - 884
An omics-based machine learning approach to predict diabetes progression: a RHAPSODY study Roderick C. SliekerMagnus MünchJoline W. J. Beulens Article Open access 19 February 2024 Pages: 885 - 894
Metabolomic and genetic architecture of gestational diabetes subtypes Kristen LeeAlan KuangWilliam L. Lowe Jr Article 17 February 2024 Pages: 895 - 907
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes Alexandra Coomans de BrachèneMaria Ines AlvelosDecio L. Eizirik Extended Article 26 February 2024 Pages: 908 - 927
Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study Franziska G. RauscherTobias ElzeMengyu Wang Article Open access 02 March 2024 Pages: 928 - 939
A loss-of-function mutation in KCNJ11 causing sulfonylurea-sensitive diabetes in early adult life Natascia VedovatoMaria V. SalgueroFrances M. Ashcroft Article Open access 17 February 2024 Pages: 940 - 951
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Rosa M. Sánchez-HernándezAna M. Wägner Letter 26 February 2024 Pages: 952 - 953
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention Frans PouwerSonya Deschênes Letter 01 March 2024 Pages: 954 - 955
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter] Merel M. RuissenEwout W. SteyerbergJacob K. Sont Letter 01 March 2024 Pages: 956 - 957
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research Jeremy Basset‑SagarminagaTineke van de WeijerVera Schrauwen‑Hinderling Correction 23 February 2024 Pages: 958 - 958